Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Stock Option Activities) (Details)

v3.22.2.2
Stockholders' Equity (Stock Option Activities) (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Options vested and expected to vest, Number of shares 1,018,490  
Number of shares, Granted 2,500  
Number of shares, Expired (370,000)  
Options vested and expected to vest, Number of shares 650,990 1,018,490
Options vested and exercisable, Number of shares 650,990  
Options vested and expected to vest, Weighted average exercise price $ 5.04  
Weighted average exercise price, Granted 2.50  
Weighted average exercise price, Expired 6.27  
Options vested and expected to vest, Weighted average exercise price 4.34 $ 5.04
Options vested and exercisable, Weighted average exercise price $ 4.34  
Total weighted average intrinsic value, Options vested and expected to vest $ 368,344  
Total weighted average intrinsic value, Options vested and expected to vest   $ 368,344
Options vested and expected to vest, Weighted average contractual life 1 year 9 months 21 days 1 year 8 months 4 days
Options Granted, weighted average remaining contractual life (years) 9 years 3 months 3 days  
Options vested and exercisable, Weighted average remaining contractual life (years) 1 year 9 months 21 days